These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12218063)

  • 1. Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy.
    Zhang RZ; Sabatelli P; Pan TC; Squarzoni S; Mattioli E; Bertini E; Pepe G; Chu ML
    J Biol Chem; 2002 Nov; 277(46):43557-64. PubMed ID: 12218063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI α2(VI) chain.
    Zamurs LK; Idoate MA; Hanssen E; Gomez-Ibañez A; Pastor P; Lamandé SR
    J Biol Chem; 2015 Feb; 290(7):4272-81. PubMed ID: 25533456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.
    Tooley LD; Zamurs LK; Beecher N; Baker NL; Peat RA; Adams NE; Bateman JF; North KN; Baldock C; Lamandé SR
    J Biol Chem; 2010 Oct; 285(43):33567-33576. PubMed ID: 20729548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
    Pan TC; Zhang RZ; Sudano DG; Marie SK; Bönnemann CG; Chu ML
    Am J Hum Genet; 2003 Aug; 73(2):355-69. PubMed ID: 12840783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
    Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
    Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.
    Zhang RZ; Zou Y; Pan TC; Markova D; Fertala A; Hu Y; Squarzoni S; Reed UC; Marie SKN; Bönnemann CG; Chu ML
    J Biol Chem; 2010 Mar; 285(13):10005-10015. PubMed ID: 20106987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.
    Pan TC; Zhang RZ; Arita M; Bogdanovich S; Adams SM; Gara SK; Wagener R; Khurana TS; Birk DE; Chu ML
    J Biol Chem; 2014 Apr; 289(15):10293-10307. PubMed ID: 24563484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity.
    Pace RA; Peat RA; Baker NL; Zamurs L; Mörgelin M; Irving M; Adams NE; Bateman JF; Mowat D; Smith NJ; Lamont PJ; Moore SA; Mathews KD; North KN; Lamandé SR
    Ann Neurol; 2008 Sep; 64(3):294-303. PubMed ID: 18825676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy.
    Lucarini L; Giusti B; Zhang RZ; Pan TC; Jimenez-Mallebrera C; Mercuri E; Muntoni F; Pepe G; Chu ML
    Hum Genet; 2005 Sep; 117(5):460-6. PubMed ID: 16075202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy.
    Giusti B; Lucarini L; Pietroni V; Lucioli S; Bandinelli B; Sabatelli P; Squarzoni S; Petrini S; Gartioux C; Talim B; Roelens F; Merlini L; Topaloglu H; Bertini E; Guicheney P; Pepe G
    Ann Neurol; 2005 Sep; 58(3):400-10. PubMed ID: 16130093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.
    Caria F; Cescon M; Gualandi F; Pichiecchio A; Rossi R; Rimessi P; Cotti Piccinelli S; Gallo Cassarino S; Gregorio I; Galvagni A; Ferlini A; Padovani A; Bonaldo P; Filosto M
    Neuromuscul Disord; 2019 Sep; 29(9):657-663. PubMed ID: 31471117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families.
    Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR
    Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.
    Gualandi F; Manzati E; Sabatelli P; Passarelli C; Bovolenta M; Pellegrini C; Perrone D; Squarzoni S; Pegoraro E; Bonaldo P; Ferlini A
    Hum Gene Ther; 2012 Dec; 23(12):1313-8. PubMed ID: 22992134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report.
    Martoni E; Petrini S; Trabanelli C; Sabatelli P; Urciuolo A; Selvatici R; D'Amico A; Falzarano S; Bertini E; Bonaldo P; Ferlini A; Gualandi F
    BMC Med Genet; 2013 Jun; 14():59. PubMed ID: 23738969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI.
    Camacho Vanegas O; Bertini E; Zhang RZ; Petrini S; Minosse C; Sabatelli P; Giusti B; Chu ML; Pepe G
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7516-21. PubMed ID: 11381124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.
    Demir E; Sabatelli P; Allamand V; Ferreiro A; Moghadaszadeh B; Makrelouf M; Topaloglu H; Echenne B; Merlini L; Guicheney P
    Am J Hum Genet; 2002 Jun; 70(6):1446-58. PubMed ID: 11992252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem.
    Zou Y; Zhang RZ; Sabatelli P; Chu ML; Bönnemann CG
    J Neuropathol Exp Neurol; 2008 Feb; 67(2):144-54. PubMed ID: 18219255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.
    Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML
    Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion.
    Lamandé SR; Shields KA; Kornberg AJ; Shield LK; Bateman JF
    J Biol Chem; 1999 Jul; 274(31):21817-22. PubMed ID: 10419498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts.
    Usuki F; Yamashita A; Kashima I; Higuchi I; Osame M; Ohno S
    Mol Ther; 2006 Sep; 14(3):351-60. PubMed ID: 16807116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.